Berthold Hackl

Berthold Hackl is an accomplished professional in the biopharmaceutical and healthcare sectors, currently serving as a Board Member at PlasmidFactory GmbH & Co. KG since November 2022, a company specializing in plasmid and minicircle DNA for therapeutic applications. Hackl also holds the position of Strategic Partner at ArchiMed and serves as Chairman at Human Med AG, focusing on medical devices for water-jet-assisted liposuction. Additionally, Hackl contributes as a Board Member for Groupe CARSO and is a Senior Advisor at Back Bay Life Science Advisors. As the Founder and Managing Director of Sorrento Investment GmbH, Hackl has extensive experience in investment and consultancy. Furthermore, Hackl leads Arthro Kinetics AG and Minitube International AG as Chairperson of the Board and has held non-executive roles at Luciole Medical AG and TSE Systems. Educational qualifications include an MBA from INSEAD and a Diploma in Molecular Biology from The University of Freiburg.